Barclays’s AC Immune ACIU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Buy |
7,907
+498
| +7% | +$1.01K | ﹤0.01% | 4104 |
|
|
2025
Q1 | $14K | Buy |
7,409
+1,537
| +26% | +$2.9K | ﹤0.01% | 4104 |
|
|
2024
Q4 | $16K | Buy |
5,872
+5,382
| +1,098% | +$14.7K | ﹤0.01% | 4131 |
|
|
2024
Q3 | $2K | Buy |
+490
| New | +$2K | ﹤0.01% | 4229 |
|
|
2021
Q4 | – | Sell |
-7,068
| Closed | -$48K | – | 3231 |
|
|
2021
Q3 | $48K | Buy |
7,068
+6,950
| +5,890% | +$47.2K | ﹤0.01% | 3395 |
|
|
2021
Q2 | $1K | Sell |
118
-274
| -70% | -$2.32K | ﹤0.01% | 4030 |
|
|
2021
Q1 | $3K | Buy |
392
+286
| +270% | +$2.19K | ﹤0.01% | 3789 |
|
|
2020
Q4 | $1K | Hold |
106
| – | – | ﹤0.01% | 3494 |
|
|
2020
Q3 | $1K | Hold |
106
| – | – | ﹤0.01% | 3676 |
|
|
2020
Q2 | $1K | Buy |
+106
| New | +$1K | ﹤0.01% | 3738 |
|
|
2020
Q1 | – | Sell |
-134
| Closed | -$1K | – | 3628 |
|
|
2019
Q4 | $1K | Sell |
134
-350
| -72% | -$2.61K | ﹤0.01% | 3802 |
|
|
2019
Q3 | $2K | Hold |
484
| – | – | ﹤0.01% | 3998 |
|
|
2019
Q2 | $3K | Buy |
+484
| New | +$3K | ﹤0.01% | 4108 |
|
|
2019
Q1 | – | Sell |
-6,378
| Closed | -$61K | – | 4243 |
|
|
2018
Q4 | $61K | Buy |
6,378
+5,606
| +726% | +$53.6K | ﹤0.01% | 3122 |
|
|
2018
Q3 | $6K | Buy |
+772
| New | +$6K | ﹤0.01% | 4048 |
|
|
2018
Q2 | – | Sell |
-5,500
| Closed | -$57K | – | 4166 |
|
|
2018
Q1 | $57K | Sell |
5,500
-4,700
| -46% | -$48.7K | ﹤0.01% | 3453 |
|
|
2017
Q4 | $131K | Buy |
+10,200
| New | +$131K | ﹤0.01% | 2872 |
|